Mechanism and response of thymoglobulin in patients with myelodysplastic syndrome (MDS)
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- 31 Jan 2014 Status changed from recruiting to completed, according to results published in the Haematologica.
- 14 May 2007 New trial record.